Compare PTGX & POR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PTGX | POR |
|---|---|---|
| Founded | 2006 | 1889 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 5.6B |
| IPO Year | 2016 | N/A |
| Metric | PTGX | POR |
|---|---|---|
| Price | $82.47 | $49.93 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 11 |
| Target Price | ★ $93.00 | $47.00 |
| AVG Volume (30 Days) | ★ 788.9K | 758.7K |
| Earning Date | 02-20-2026 | 02-20-2026 |
| Dividend Yield | N/A | ★ 4.16% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.72 | ★ 2.78 |
| Revenue | $209,217,000.00 | ★ $3,511,000,000.00 |
| Revenue This Year | N/A | $4.56 |
| Revenue Next Year | $409.41 | $5.03 |
| P/E Ratio | $115.35 | ★ $18.18 |
| Revenue Growth | N/A | ★ 5.09 |
| 52 Week Low | $33.70 | $39.55 |
| 52 Week High | $96.54 | $51.14 |
| Indicator | PTGX | POR |
|---|---|---|
| Relative Strength Index (RSI) | 44.12 | 57.66 |
| Support Level | $81.94 | $48.87 |
| Resistance Level | $85.50 | $50.51 |
| Average True Range (ATR) | 3.16 | 0.81 |
| MACD | 0.02 | 0.09 |
| Stochastic Oscillator | 40.39 | 68.88 |
Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.
Portland General Electric is a regulated electric utility providing generation, transmission, and distribution services in a service territory that includes about half of all Oregon residents and two-thirds of the state's business activity. The company owns (wholly or through joint ventures) 3.5 gigawatts of gas, coal, wind, and hydro generation along with 300 megawatts of energy storage.